Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
Open Access
- 1 December 1980
- journal article
- research article
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 34 (4) , 253-257
- https://doi.org/10.1136/jech.34.4.253
Abstract
Histocompatibility testing was performed in 48 multiple sclerosis patients and two carefully matched control groups in Orkney Islands, an area of high multiple sclerosis prevalence. The frequency of HLA-A3, HLA-B7, and DW2 was comparable in patients and controls. However, HLA-B7 was significantly more common in female patients compared with male patients. A B-cell alloantigen (B-cell 4) was also as frequent in patients as among controls. Strong linkage between HLA-B7, DW2 and B-cell 4 occurred in controls, but not patients; the linkage was particularly striking in female controls. These data are not consistent with theories that relate certain of the histocompatibility antigens to the aetiology of multiple sclerosis.This publication has 20 references indexed in Scilit:
- B-LYMPHOCYTE ALLOANTIGENS ASSOCIATED WITH MULTIPLE SCLEROSISThe Lancet, 1976
- Multiple Sclerosis and High Incidence of a B Lymphocyte AntigenScience, 1976
- B-lymphocyte alloantigens in Caucasians.The Journal of Experimental Medicine, 1976
- B-cell alloantigen Ag 7a in multiple sclerosisThe Lancet, 1975
- Histocompatibility Determinants in Multiple SclerosisImmunological Reviews, 1975
- HL-A ANTIGENS IN MYASTHENIA GRAVISThe Lancet, 1974
- HL‐A Polymorphism of Norwegian LappsTissue Antigens, 1971
- A SEMIMICRO MIXED LEUKOCYTE CULTURE TESTTransplantation, 1971
- Microdroplet Assay of Human Serum CytotoxinsNature, 1964
- FAMILIAL AND CONJUGAL MULTIPLE SCLEROSISBrain, 1963